Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study-Reference-Cited by-同舟云学术

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

Published:2016 Issue:14 Volume:7 Page:2077-2084
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Boudin Laurys,Gonçalves Anthony,Sfumato Patrick,Sabatier Renaud,Bertucci François,Tarpin Carole,Provansal Magali,Houvenaeghel Gilles,Lambaudie Eric,Tallet Agnes,Resbeut Michel,Charafe-Jauffret Emmanuelle,Calmels Boris,Lemarie Claude,Boher Jean-Marie,Extra Jean-Marc,Viens Patrice,Chabannon Christian

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of neoadjuvant chemotherapy on the structural and functional state of tumor cells in the secondary edematous form of breast cancer;Український радіологічний та онкологічний журнал;2022-06-30

2. Special Clinical Settings: Tumors Arising in Pregnancy, Pregnancy-Like (Pseudolactational) Proliferations, Breast Carcinoma in the Pre-neoadjuvant Chemotherapy Setting, Recurrent Breast Carcinoma, and Inflammatory Breast Carcinoma;A Comprehensive Guide to Core Needle Biopsies of the Breast;2022

3. Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC;Cancers;2020-09-17

4. Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease;Case Reports in Oncology;2018-12-19

5. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes;Clinical Breast Cancer;2018-08